Send a message to the show! What did the drug safety community achieve in 2023 and how will the field develop in 2024? As the year comes to a close, we asked Angela Caro-Rojas, president of the International Society of Pharmacovigilance (ISoP), to walk us through current and future trends in pharmacovigilance. Tune in to find out: Why patient engagement is a ... Show More
Feb 2026
#44 Rethinking medical device safety, part 2 – Omar Aimer
Send a message to the show!Medical device pharmacovigilance is complicated. Alongside clinical safety, there are technology risks, from cybersecurity threats to outdated software, that can put patients at risk. In this two-part episode, Omar Aimer, President of ISoP and former co ... Show More
21m 22s
Apr 2024
The Power of Drug Discovery with Philip Tagari
<p>Philip Tagari, Chief Scientific Officer of insitro, joins Vijay Pande, founding general partner at a16z Bio + Health.</p><p>Together, they discuss the transformative power of drugs in changing human health—and history. They also reflect on the evolution of the drug discovery p ... Show More
31m 36s
Jun 2023
Highlights From the 2023 American Society of Clinical Oncology Annual Meeting
<p>JAMA Deputy Editor and JAMA Oncology Editor Mary (Nora) L. Disis, MD, speaks with Kimmie Ng, MD, MPH, chair of the meeting's Scientific Program Committee and associate chief of the Division of Gastrointestinal Oncology at Dana-Farber Cancer Institute.<br /> <br /> <strong>Rela ... Show More
21m 41s
Nov 2022
WISH 2022 - Antimicrobial resistance, and workforce wellbeing
Last month, saw the WISH 2022 - the World Innovation Summit for Health, where experts from around the world came and presented their ideas.
In this podcast we'll hear from Dame Sally Davies, the UK’s Special Envoy on Antimicrobial Resistance - she explains how covid, and treatme ... Show More
43m 10s
Jan 2023
#376 Hormone Therapy for Primary Prevention of Chronic Conditions in Postmenopausal Persons - a USPSTF update with Dr. Carol Mangione
We have better tools for prevention, but let’s talk!Should we be offering hormone therapy for primary prevention in postmenopausal patients? Dr. Carol Mangione (UCLA) talks us through the potential benefits and harms, and explains how this can be a jumping off point for important ... Show More
26m 57s
<p><span class="normaltextrun"><span style= "font-size: 11.0pt; line-height: 107%; font-family: 'Aptos',sans-serif; mso-fareast-font-family: 'Times New Roman'; mso-fareast-theme-font: major-fareast; mso-bidi-font-family: 'Segoe UI'; mso-ansi-language: EN-US; mso-fareast-language: ... Show More
